BARCELONA, Spain, May 21 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a world leader in products and technologies to treat advanced cardiovascular disease, today announced its schedule for symposia and sessions of interest at EuroPCR 2007, from May 22 through 25 in Barcelona, Spain. Clinicians will present new data and results on Edwards SAPIEN transcatheter heart valve, Edwards MONARC system for functional mitral regurgitation and Edwards LifeStent peripheral vascular stent system. Representatives from Edwards Lifesciences will also be in the exhibition area at Stand E12.
Wednesday, May 23 * Symposium -- 12:00-13:30, Room 5, "Changing Dynamics and Treatment Options for Treating Aortic Stenosis." Ted Feldman, M.D., of the Department of Medicine of Northwestern University's Feinberg School of Medicine, and colleagues will present information on the evolution of treatment options for patients with severe aortic stenosis, in addition to clinical updates on the next-generation Edwards Transcatheter Heart Valve (THV) systems, including the Edwards SAPIEN transcatheter heart valve utilized in the pivotal PARTNER trial now underway. Thursday, May 24 * Symposium -- 16:30-18:00, Room 5, "Transcatheter Mitral Valve Repair -- Treating Functional Mitral Regurgitation (FMR) in Heart Failure Patients." Gregg W. Stone, M.D., Director of Cardiovascular Research and Education, Center for Interventional Vascular Therapy, at Columbia University Medical Center, will chair this symposium. Dr. Stone and his colleagues will present information about managing heart failure patients with functional mitral regurgitation and present interim data from the EVOLUTION study with the Edwards MONARC system. Friday, May 25 * Focus session -- 09:00-11:30, Room 7, "Challenges and progress in treating chronic limb ischemia and lower limb occlusive disease." Giancarlo Biamino, M.D., of the Gruppo Villa Maria Endovascular, and colleagues will discuss how to approach complex tibial lesions, how to choose the dedicated technique for recanalisation and how to evaluate the long-term clinical outcome, featuring a live case transmission from Leipzig and information about Edwards LifeStent peripheral vascular stent system. Sessions of Interest * May 22, "TVS@EuroPCR -- Back to Basics -- I," 14:00-18:00, Room 3, featuring live case transmission. * May 23, "TVS@EuroPCR -- Back to Basics -- II -- Imaging," 08:00-12:00, Room 3, featuring imaging for aortic valve replacement and for repair of functional mitral regurgitation. * May 23, "The Surgeons Meet the Cardiologists -- Percutaneous Valve Intervention, Part I: Mitral Regurgitation," 08:00-12:00, Room 8, featuring discussions about percutaneous treatment of mitral regurgitation. * May 23, "The Surgeons Meet the Cardiologists -- Percutaneous Valve Intervention, Part II: Aortic Stenosis," 13:30-16:30, Room 8, featuring live case transmission. * May 23, "TVS@EuroPCR -- New Technology on Percutaneous Valve Implantation," 13:30-16:30, Room 3, featuring technology overviews. * May 24, "TVS@EuroPCR -- Percutaneous Mitral Valve Repair: Clinical Evaluation," 08:00-11:50, Room 3, featuring new clinical experiences with the MONARC system and a recorded MONARC system case. * May 24, "Strategies for Complex Superficial Femoral Artery Reconstruction: Lesion Based Analysis," 08:05-8:50, Room 2. * May 24, "Cardiologists and Surgeons Perspective on Percutaneous Aortic Valve Implantation -- a Positive Attitude," 12:00-13:30, Room 3. * May 25, "TVS@EuroPCR -- Percutaneous Valve Implantation: Clinical Evaluation," 08:00-12:00, Room 3, featuring clinical results of the percutaneous Edwards SAPIEN aortic valve.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards, Edwards SAPIEN and MONARC are trademarks of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.
Edwards Lifesciences CorporationCONTACT: Media, Nolan Taira, +1-949-250-5070, or Investors, David K.Erickson, +1-949-250-6826, both of Edwards Lifesciences Corporation
Web site: http://www.edwards.com/
